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Abstract
A genomewide linkage scan was carried out in eight clinical samples of informative schizophrenia
families. After all quality control checks, the analysis of 707 European-ancestry families included
1,615 affected and 1,602 unaffected genotyped individuals, and the analysis of all 807 families
included 1900 affected and 1839 unaffected individuals. Multipoint linkage analysis with correction
for marker-marker linkage disequilibrium was carried out with 5,861 single nucleotide
polymorphisms (SNPs; Illumina 4.0 linkage map). Suggestive evidence for linkage (European
families) was observed on chromosomes 8p21, 8q24.1, 9q34 and 12q24.1 in non-parametric and/or
parametric analyses. In a logistic regression allele-sharing analysis of linkage allowing for intersite
heterogeneity, genomewide significant evidence for linkage was observed on chromosome 10p12.
Significant heterogeneity was also observed on chromosome 22q11.1. Evidence for linkage across
family sets and analyses was most consistent on chromosome 8p21, with a one-lod support interval
that does not include the candidate gene NRG1, suggesting that one or more other susceptibility loci
Contact: Douglas F. Levinson, M.D., Department of Psychiatry, Stanford University, 701 Welch Rd. Suite A-3325, Palo Alto, CA 94305
(650-724-2827, fax 650-724-3263, dflev@stanford.edu).
NIH Public Access
Author Manuscript
Mol Psychiatry. Author manuscript; available in PMC 2010 February 1.
Published in final edited form as:
Mol Psychiatry. 2009 August ; 14(8): 786–795. doi:10.1038/mp.2009.11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
might exist in the region. In this era of genomewide association and deep resequencing studies,
consensus linkage regions deserve continued attention, given that linkage signals can be produced
by many types of genomic variation, including any combination of multiple common or rare SNPs
or copy number variants in a region.
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Introduction
Two major methods are currently available to scan the genome to detect disease susceptibility
loci: genomewide linkage studies (GWLS) and genomewide association studies (GWAS). We
report here on a GWLS of eight samples of families with multiple cases of schizophrenia (SCZ)
using a dense map of single nucleotide polymorphism (SNP) markers, and the companion
paper1 reports on a meta-analysis of thirty-two SCZ GWLS including the eight samples studied
here.
GWLS uses hundreds or thousands of DNA markers to detect the broad regions (millions of
base pairs) within which there are most likely to be disease susceptibility loci, based on the
pattern of within-family correlations between marker alleles and disease. GWAS uses hundreds
of thousands of SNPs that tag (serve as proxies for) most of the common SNPs in the genome,
to identify small regions (tens of thousands of base pairs) likely to harbor susceptibility variants.
GWAS can detect loci with much weaker genetic effects if they are due to common SNPs. For
common, genetically complex disorders, GWAS have proven more successful than GWLS in
producing robust and well-replicated associations.2 However, there are genetic effects for
which GWLS can be more powerful, including loci with multiple rare pathogenic mutations
in different families, or several different susceptibility loci in the same region.
The present study is a collaboration of seven research groups using pedigree samples collected
by each group3–11 plus a publicly-available sample12, totalling over 800 pedigrees with ill
individuals in constellations that are informative for linkage analysis. We previously carried
out a set of studies of candidate linkage regions.13–16 We now report on a new genomewide
linkage scan of the entire sample. Whereas previously around 70% of these families had been
included in published linkage scans using microsatellite markers3,5,6,10,11,17–19, we have now
scanned all available families using a set of almost 6,000 SNP markers genotyped with high
accuracy, extracting on average around 90% of the possible linkage information from these
pedigrees. In analyses of 707 European-ancestry pedigrees, significant linkage accounting for
cross-site heterogeneity was observed on chromosome 10p, and suggestive evidence for
linkage on chromosomes 8p, 8q and 12q, as well 9q when non-European families were
included.
Materials and Methods
Subjects
The sample is described in Tables 1 and 2. Recruitment by each research group has been
previously described.3–12 Here, affected cases included probands with DSM-IIIR diagnoses
of SCZ and relatives with SCZ or schizoaffective disorder, which co-segregates with SCZ in
families20 and is often not differentiated reliably from SCZ.21 Consensus diagnoses were based
on information from semi-structured interviews, psychiatric records and family informants.
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Genotyping
Genotyping was carried out at the Center for Inherited Disease Research (CIDR) using the
Illumina GoldenGate assay22 to analyze the Illumina version 4 linkage marker set of 6,008
SNPs. SNPs were excluded by CIDR (N=53) based on internal quality control (QC) criteria,
and by the investigators (N=36) for more than 3 parent-child inheritance errors or deviation
from Hardy-Weinberg equilibrium at p < 0.001, leaving 5,861 autosomal or X chromosome
SNPs for analyses. deCODE23 map locations were provided by Illumina. There were 0.09%
missing genotypes, 0.12% Mendelian inconsistencies prior to QC checks (0.00138% in the
analyzed SNPs), and 0.002% discordant genotypes in 224 blind duplicate specimens. There
were 132 DNAs excluded for poor performance in genotyping of a preliminary forensic panel
or the full SNP panel; and 60 for inconsistency with reported sex, Mendelian inconsistencies
greater than 0.5% or sample call rates less than 98%.
Pedigree relationship analyses
Pairwise identity-by-descent (IBD) proportions were analyzed for all pairs of subjects using
PLINK24, and differences between specified and actual relationships within families were
analyzed using PREST.25 As a result, 50 DNAs were excluded to resolve pairs of identical
specimens, 3 families were excluded because genotypic relationships did not fit the family and
8 because the same family was found in two different samples (JHU-NIMH, JHU-ENH, ENH-
NIMH or Cardiff-VCU). Pedigree structures were also corrected (e.g., half-sib vs. full-sib
relationships) as required.
Because of the high accuracy of genotyping with a dense SNP map that facilitated analysis of
relationships, and the enlarged samples, the present data replace previous analyses of candidate
regions by this collaboration for this narrow phenotypic model.13–16
Assignment of families to ancestry subsamples
Families were assigned to predominantly European (EUR), African-American or African-
European (AFR), or “other” (OTH) groups based on STRUCTURE26 analysis of 49
independent autosomal SNPs which had large allele frequency differences between ancestries
(0.5–0.69 EUR vs. AFR, 0.3–0.47 for EUR vs. OTH) in this sample based on investigator-
reported ancestries, or based on public databases. EUR or AFR families had an estimated 70%
or more ancestry from that group, otherwise the family was considered OTH. Members of these
groups had a mean 98% or 96% ancestry, respectively, from that group. Analyses were carried
out for EUR families and then for ALL families (using allele frequencies estimated separately
for EUR, AFR and OTH groups27).
Statistical analyses
The planned primary multipoint linkage analysis of EUR families used the SPAIRS statistic
(ZLikelihoodRatio and its Kong-Cox equivalent lod score28 under the exponential model)
computed with MERLIN29 using MERLIN’s correction for LD within clusters of markers
based on a threshold of r2 greater than 0.05 for consecutive pairs of markers30. Prior to analyses,
unlikely genotypes were detected and excluded using MERLIN.31
Additional analyses included: (1) SPAIRS analysis of ALL families using ALLEGRO 2.032
(analyzing each ancestry subset with it own allele frequencies) with a “no-LD map” of 4,365
autosomal and X chromosome SNPs with no marker-marker r2 greater than 0.05 (because
ALLEGRO cannot correct for LD); (2) the Kong-Cox exponential SALL statistic which gives
more weight to larger families (results were similar and are not shown here, but are included
in online supplementary files); (3) parametric heterogeneity lod score (hlod) analysis under
dominant (risk allele frequency = 0.05; penetrances = 0, 0.001 and 0.001) and recessive (risk
Holmans et al. Page 3
Mol Psychiatry. Author manuscript; available in PMC 2010 February 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
allele frequency = 0.1, penetrances = 0, 0 and 0.001) models, using MERLIN for EUR and
ALLEGRO (and the no-LD map) for ALL families; (3) logistic regression analysis of IBD
sharing33,34 to assess heterogeneity across sites, linkage while accounting for heterogeneity,
effects of parent-of-origin of each allele and of sex of the affected pair (M-M, M-F, F-F), and
interactions between linkage regions (see online Supplementary Table 5 for description).
Thresholds for significant (0.05 or fewer peaks expected genomewide per genome scan) and
suggestive (less than 1 peak per scan) evidence for linkage were determined by simulation for
nonparametric and parametric analyses analysis using data generated under the assumption of
no linkage. “Peaks” were defined as local maxima at least 30 cM from another peak. The
empirical threshold for parametric analysis was corrected for two tests by taking the maximum
result of the dominant and recessive analyses of simulated replicates at each point.
Data sharing
All genotypic data for this study will be made available to qualified scientists by the NIMH
Center for Genetic Studies (nimhgenetics.org).
Results
Nonparametric and parametric linkage analyses
The empirical lod or hlod thresholds for suggestive linkage were 1.94 for nonparametric and
2.21 for parametric tests, or 3.26 and 3.66 for significant linkage. Mean information content
was 0.88 (S.D. 0.026) using MERLIN’s entropy measure (reflecting potential information with
fully informative markers) and 0.908 (SD, 0.028) using ALLEGRO’s exponential measure
(measuring potential information given the constellation of genotyped relatives).
Figure 1 shows Kong-Cox lods and dominant and recessive hlod scores for EUR and ALL
families. Table 2 lists the maximum lod and hlod scores in each analysis on each chromosome.
The nonparametric analysis of EUR families, considered the primary analysis here, produced
suggestive evidence for linkage on chromosome 8p21 (in EUR families, lod = 2.00, 45.9 cM;
in ALL families, lod = 2.51, 46.4 cM, with the latter, larger score at 26.61 bp). The dominant
and recessive analyses were considered an alternative approach, and suggestive evidence for
linkage (taking both tests into account as noted above) was observed on chromosomes 8p21,
8q24.1, 9q34 and 12q24.1 in non-parametric and/or parametric analyses (see Table 1 for
details). Evidence for linkage was most consistent for chromosome 8p21 (five of the six
analyses).
Heterogeneity and linkage allowing for heterogeneity
Table 3 shows the results of the logistic regression analysis of linkage while allowing for
intersite heterogeneity, in EUR families. Highly significant genomewide evidence for linkage
with heterogeneity was observed on chromosome 10p12 (see Table 3 legend for additional
details). Chromosome 8p21 again produced suggestive evidence for linkage both with and
without heterogeneity in this analysis. Results of tests for intersite heterogeneity (i.e., the
difference between lods with and without allowing for heterogeneity) are shown in online
Supplementary Table 1. Significant heterogeneity was observed on chromosome 10p (45.6
cM) and 22q11.1 (0 cM).
Supplementary online files provide details of parametric and nonparametric linkage scores,
genetic location and information content for each analyzed point for each analysis in the entire
sample for EUR and ALL families, as well as the full and No-LD marker maps. Online files
for the companion meta-analysis paper1 provide ranked results for each of our 8 samples
separately and for EUR and ALL families separately.
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Other analyses
No significant chromosome-wide effects were observed for sex of the affected pair or parent
of origin (online Supplementary Tables 3 and 4). Online Supplementary Table 5 shows results
of interaction analyses for all pairs of 18 regions with Kong-Cox lod scores greater than 1. No
genomewide significant interactions were observed. The online table legend includes a list of
the most significant empirical interaction p-values.
Discussion
Suggestive evidence for linkage was detected on chromosome 8p21 in multiple analyses: in
nonparametric, dominant and recessive analyses of 707 European-ancestry families, and in
nonparametric and dominant analyses of all 807 families.
This same region produced suggestive evidence for linkage (and the largest peak), in the
independent Molecular Genetics of Schizophrenia (MGS) sample35 of 409 European-ancestry
and African American families. Our peak results were between 45.9–46.8 cM (between
rs1561817 and rs9797, 26.59–27.65 Mb; deCODE linkage map and genome build 36.3 physical
locations). The MGS peak was at 43.3 cM for all families (near rs196886 at 24.79 Mb), while
in European-ancestry families it was at 15.3 cM (8p23, near rs7834209 at 6.9 Mb), with a
slightly smaller peak at 34.6 cM (8p21, near rs34393111 at 20.28 Mb), and suggestive evidence
for linkage extended beyond our peak scores. Pulver and colleagues were the first to report
preliminary36 and then strongly suggestive evidence10 for linkage of SCZ to chromosome 8p
markers in much of the JHU sample that is included here. We previously reported support for
8p linkage in a study of microsatellite markers in a majority of the families in the present
analysis13, consistent with results in this enlarged sample.
The most widely-studied 8p candidate gene is NRG1 (neuregulin 1), found to be associated
with SCZ by Stefansson et al.37 in a linkage disequilibrium mapping study of a suggestive
linkage peak observed in Icelandic families (there were two 8p peaks in that analysis, with the
second one closer to ours), with supportive evidence in some datasets.38 There are several
indications that, if there is linkage on chromosome 8p, it is not entirely explained by NRG1.
Here, lod scores within one unit of the maximum (1-lod interval) were observed between 21.37–
29.36 Mb, whereas NRG1 is between 32.53–32.74 Mb. (The 1-lod interval is a reliable
confidence interval in studies of Mendelian disorders, but not for complex disorders.) In the
companion meta-analysis paper1, the second “bin” on chromosome 8 (8.2, 28.1–56.2 cM, ~
15.7–33 Mb) produced the strongest (suggestive) evidence for linkage in 22 European-ancestry
datasets, and was ranked eighth in the analysis of all 32 datasets. NRG1 is at the centromeric
edge of that bin (~ 55.7 cM), so one would expect that if it explained the linkage, the signal
would extend equally in the centromeric and telomeric directions, but support for linkage was
not observed in more centromeric bins (bin 8.3 in the primary analysis, from 56.2–84.3 cM;
bin 8.4 in the “20 cM” analysis from 56.2–75 cM; or bin 8.3 in the “30 cM” shifted analysis
from 42.15–70.25 cM).1 We hypothesize that there is weak linkage to SCZ on chromosome
8p, due to one or more loci in which there are multiple rare risk-associated SNPs and/or
structural variants and/or multiple associated common SNPs. There are other candidate genes
on 8p (see discussion in the meta-analysis paper1), it is not yet clear what accounts for the
evidence for linkage in this region.
Suggestive evidence for linkage was observed on chromosome 9q in the dominant analysis of
all families. Support for this region in other analyses was modest, but not substantially different
than the evidence for 8p. This region is not supported by previous linkage findings or the meta-
analysis.1
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Genomewide significant evidence for linkage allowing for intersite heterogeneity was
observed on chromosome 10p12 at 45.6 cM (21.28 Mb). We previously reported modest
evidence for heterogeneity in this region14, and in that report we also reviewed the evidence
for 10p linkage reported previously in the NIMH-SGI, VCU/Ireland and part of the Bonn/Perth
samples studied here. A significant signal is now seen in the present expanded sample, with a
denser marker map, due to allele sharing in the Paris/CNRS, NIMH-SGI and (to a lesser degree)
the VCU samples (online Supplementary Table 2). There is no indication of a high-penetrance
signal from a small subset of families: the NIMH sample includes small nuclear families from
the general U.S. population; and although there are some large, extended pedigrees in the Paris/
CNRS sample from La Réunion Island, most of the families with positive lod scores were small
families from the general French population, and no single family had a lod score (Kong-Cox,
dominant or recessive) greater than 1.4. Because we combined families from eight previously-
colected datasets, we do not have a consistent set of clinical ratings across samples to search
for a possible clinical basis for linkage heterogeneity. The 10p peak is not supported by meta-
analysis1, and is far from the chromosome 10q peaks observed between 100–110 cM in two
independent studies39,40.
Significant heterogeneity (but not linkage with heterogeneity) was seen on chromosome 22q
at 15 Mb, adjacent to the typical region (17–21 Mb) of the 22q11 deletion syndromes whose
manifestations include SCZ in approximately 20% of cases.41 This deletion was detected in
less than 0.5% of SCZ cases in two recent large studies.42,43 No consistent association signals
have been observed to date between SCZ and common SNPs in candidate genes within the
deletion region.
Two other regions, on chromosomes 8q24.1 and 12q24.1, produced suggestive evidence for
linkage in at least one analysis, both reportedly linked to mood disorders rather than SCZ. On
8q, a combined analysis of genotypes from 11 linkage scans (1,067 families) produced a
nonparametric lod score of 3.40 at 134.5 Mb, just telomeric to our 1-lod interval, in an analysis
of bipolar-I and bipolar-II cases, but the signal was much smaller in an analysis of only bipolar-
I.44 Given that by definition only bipolar-I can include psychosis (usually in around half of
cases), one would not predict that the same locus in this region would account for linkage
signals to bipolar disorder and SCZ. On chromosome 12q, there have been reports of linkage
to major depressive45,46 and bipolar disorders (see review by Barden et al.47) with peak
locations ranging from 97.4–126.5 Mb -- 116–126 Mb in bipolar studies, close to our peak at
111 Mb. Neither region was supported by the SCZ linkage meta-analysis.1
In the linkage meta-analysis1, genomewide significant evidence for linkage was detected on
chromosome 2q (132–162 cM, 121–152 Mb), with some support for linkage across a broad
region (118–176 cM and 206–235 cM). In the present study, we see a jagged line across
chromosome 2q (Figure 1), reflecting diverse peaks in different samples, although without
statistically significant evidence for heterogeneity. Our largest peak was in the nonparametric
EUR analysis at 206.6 cM (210.87 Mb). Thus, in our data and in the meta-analysis of 32
datasets, linkage evidence on 2q is intriguing but poorly localized. Thus, in our data and in the
meta-analysis of 32 datasets, linkage evidence on 2q is intriguing but poorly localized. It was
recently reported that a SNP in ZNF804A, at 185 Mb on 2q, produced genomewide significant
evidence for linkage when a large collaborative SCZ association sample was combined with
bipolar disorders cases from the Wellcome Trust Case Control Consortium project.48
What is the relevance of linkage studies as the field moves on to GWAS and large-scale
resequencing methods? Meta-analysis provides some support for quite modest linkage signals.
1 Thus, no gene is likely to have a large effect on overall population risk. In this situation,
GWAS methods have better power2, but (currently) only for common SNPs. GWAS
technologies can also detect some but not all copy number variants (CNVs). Recent studies
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suggest that rare deletions on chromosomes 1q and 15q (as well as 22q11) predispose to
SCZ42,43,49, 50; and that SCZ cases also have a small but significant excess of very rare CNVs,
some of which might therefore also be pathogenic. These findings support the more general
hypothesis of multiple rare genomic events (SNPs, CNVs, other structural changes) influencing
risk for a common disease.51–53
High-penetrance CNVs like those on 1q and 15q have effects such as mental retardation and/
or autism, consistent with the observation that they reduce fertility and thus are usually de
novo mutations rather than transmitted in families. But most SCZ risk variants probably have
smaller effects: the risk to probands’ siblings is around 5%20, and if one allows for a small
proportion of cases to be due to high-penetrance CNVs, the remaining risk should be due to
lower-penetrance variants which would thus be transmitted in families. It is possible that weak
SCZ linkage signals are in regions where there are multiple rare as well as common risk
variants, whose aggregate frequency and effects are sufficient to produce a linkage signal, and
whose effects on fertility are not too severe. We refer here both to deleterious transmitted and/
or recurring sequence and structural polymorphisms with low population frequencies, and to
very rare and thus very deleterious variants that segregate in different families, i.e., extreme
allelic heterogeneity.
One approach to finding these variants would be high-throughput resequencing studies of
linkage regions. For example, significant differences have been found in the proportions of
high- and low-risk individuals carrying very rare non-synonymous coding SNPs for some
diseases.54–55 This approach has not yet been attempted for schizophrenia in a large sample,
thus we lack information to predict the power or optimal design of such studies. If a region in
fact contained a sufficient number of rare high-risk variants to produce a linkage signal, then
it might be possible to detect them via resequencing, although success would depend on the
the proportion of subjects of families carrying such variants, and by the extent of locus
heterogeneity, i.e., if a small proportion of cases carried rare risk variants at a large number of
loci in a linkage region, studies of a feasible sample size might not detect them. It is not known
whether it will prove most productive to resequence exons, entire genes with their nearby
regulatory regions, or entire linkage regions (given that there are likely to be relevant
unannotated intergenic regulatory sequences). Family-based samples might be particularly
useful for resequencing studies of linkage peaks, if rare variants were contributing to the signal.
But it also possible that because these variants are rare precisely because they reduce fertility,
they could be more easily found in case-control samples, which are also larger. In our view,
multiple strategies should be attempted.
It has also been suggested that the power of GWAS can be increased by upweighting evidence
for association based on linkage scores (resulting in a small downweighting of other regions).
56 Whether or not this formal approach is used, it would be reasonable to consider linkage
findings when selecting genes and regions for dense LD mapping and large-scale resequencing
studies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Genomewide linkage results
Shown for 707 European ancestry families (top) and for all 807 families (bottom) are linkage
results across the genome. The X-axis values are cumulative chromosomal locations in
centiMorgans (deCODE map), with chromosome boundaries shown as vertical gridlines. The
Y-axis values are Kong-Cox lod scores for nonparametric analyses, or heterogeneity lod (hlod)
scores for parametric analyses. Black lines represent nonparametric lod scores, red lines
represent hlod scores under a dominant model, and purple lines represent hlod scores under a
recessive model (see text for details of the models). Dotted lines show the empirical thresholds
for genomewide suggestive evidence for linkage (less than 1 peak of this magnitude expected
by chance, in the absence of linkage) for nonparametric and parametric analyses. The
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parametric threshold takes into account that two such tests (dominant and recessive) were
performed.
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